Franklyn J Saracino Jr Dmd Pa | |
1484 Route 31 N Walnut Pond Prof Bldg Annanddale NJ 08801 | |
(908) 735-8188 | |
Not Available |
Full Name | Franklyn J Saracino Jr Dmd Pa |
---|---|
Speciality | Dentist - General Practice |
Location | 1484 Route 31 N, Annanddale, New Jersey |
Authorized Official Name and Position | Franklyn John Saracino (PRESIDENT) |
Authorized Official Contact | 9087358188 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Franklyn J Saracino Jr Dmd Pa Po Box 5314 1484 Route 31 N Walnut Pond Prof Bldg Clinton NJ 08809-0314 Ph: (908) 735-8188 | Franklyn J Saracino Jr Dmd Pa 1484 Route 31 N Walnut Pond Prof Bldg Annanddale NJ 08801 Ph: (908) 735-8188 |
NPI Number | 1013035559 |
---|---|
Provider Enumeration Date | 03/26/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1013035559 | NPI | - | NPPES |
2902702 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 22D100937400 (New Jersey) | Primary |
News Archive
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
A hard tackle on the football-field, a crash on your bike or a fall from a ladder in your home can easily cause a concussion, which eventually can cost your job - especially if you are in your thirties, and have a higher education.
Scientists at The Scripps Research Institute have published one of the first laboratory studies of MDPV, an emerging recreational drug that has been sold as "bath salts."
New data from Boehringer Ingelheim's interferon-free SOUND-C3 study were presented during the APASL Liver Week in Singapore. The Phase IIb study investigated the efficacy and safety of faldaprevir+ and deleobuvir+ (BI 207127) plus ribavirin in treatment-naïve patients with genotype-1b (GT-1b) hepatitis C virus (HCV),1 one of the most common types of HCV globally.2
› Verified 6 days ago